Price
$0.36
Change
-$0.00 (-0.00%)
Updated
Jun 8, 6:59 PM EST
GET INTRADAY SIGNALS
19 days until earnings call
Price
$206.19
Change
-$1.81 (-0.87%)
Updated
Jun 8, 6:59 PM EST
GET INTRADAY SIGNALS
55 days until earnings call

Compare trend and price AEMD vs STE

Header iconAEMD vs STE Comparison
Open Charts AEMD vs STEBanner chart's image
Aethlon Medical
Price$0.36
Change-$0.00 (-0.00%)
Volume$66.55K
CapitalizationN/A
GET INTRADAY SIGNALS
STERIS
Price$206.19
Change-$1.81 (-0.87%)
Volume$47.38K
CapitalizationN/A
GET INTRADAY SIGNALS
View a ticker or compare two or three
AEMD vs STE Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
AEMD vs. STE commentary
Jun 09, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEMD is a StrongBuy and STE is a Hold.

COMPARISON
Comparison
Jun 09, 2023
Stock price -- (AEMD: $0.34 vs. STE: $206.21)
Brand notoriety: AEMD and STE are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AEMD: 9% vs. STE: 58%
Market capitalization -- AEMD: $7.9M vs. STE: $20.34B
AEMD [@Medical Specialties] is valued at $7.9M. STE’s [@Medical Specialties] market capitalization is $20.34B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AEMD’s FA Score shows that 0 FA rating(s) are green whileSTE’s FA Score has 2 green FA rating(s).

  • AEMD’s FA Score: 0 green, 5 red.
  • STE’s FA Score: 2 green, 3 red.
According to our system of comparison, STE is a better buy in the long-term than AEMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AEMD’s TA Score shows that 3 TA indicator(s) are bullish while STE’s TA Score has 4 bullish TA indicator(s).

  • AEMD’s TA Score: 3 bullish, 5 bearish.
  • STE’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, STE is a better buy in the short-term than AEMD.

Price Growth

AEMD (@Medical Specialties) experienced а +11.18% price change this week, while STE (@Medical Specialties) price change was +1.87% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.35%. For the same industry, the average monthly price growth was +0.68%, and the average quarterly price growth was +24.25%.

Reported Earning Dates

AEMD is expected to report earnings on Aug 09, 2023.

STE is expected to report earnings on Aug 02, 2023.

Industries' Descriptions

@Medical Specialties (+1.35% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for AEMD with price predictions.
OPEN
A.I.dvisor published
a Summary for STE with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
STE($20.3B) has a higher market cap than AEMD($7.9M). AEMD YTD gains are higher at: 24.946 vs. STE (11.925). STE has higher annual earnings (EBITDA): 821M vs. AEMD (-13.02M). STE has more cash in the bank: 208M vs. AEMD (17.5M). AEMD has less debt than STE: AEMD (1.27M) vs STE (3.27B). STE has higher revenues than AEMD: STE (4.96B) vs AEMD (13.1K).
AEMDSTEAEMD / STE
Capitalization7.9M20.3B0%
EBITDA-13.02M821M-2%
Gain YTD24.94611.925209%
P/E RatioN/A192.31-
Revenue13.1K4.96B0%
Total Cash17.5M208M8%
Total Debt1.27M3.27B0%
FUNDAMENTALS RATINGS
AEMD vs STE: Fundamental Ratings
AEMD
STE
OUTLOOK RATING
1..100
1141
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
10018
SMR RATING
1..100
9786
PRICE GROWTH RATING
1..100
7450
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AEMD's Valuation (52) in the Medical Specialties industry is in the same range as STE (80). This means that AEMD’s stock grew similarly to STE’s over the last 12 months.

STE's Profit vs Risk Rating (18) in the Medical Specialties industry is significantly better than the same rating for AEMD (100). This means that STE’s stock grew significantly faster than AEMD’s over the last 12 months.

STE's SMR Rating (86) in the Medical Specialties industry is in the same range as AEMD (97). This means that STE’s stock grew similarly to AEMD’s over the last 12 months.

STE's Price Growth Rating (50) in the Medical Specialties industry is in the same range as AEMD (74). This means that STE’s stock grew similarly to AEMD’s over the last 12 months.

STE's P/E Growth Rating (11) in the Medical Specialties industry is significantly better than the same rating for AEMD (100). This means that STE’s stock grew significantly faster than AEMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AEMDSTE
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
49%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
43%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
57%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
63%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
58%
Advances
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 2 days ago
62%
Declines
ODDS (%)
Bearish Trend 15 days ago
88%
Bearish Trend 10 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
56%
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GAU0.590.03
+5.00%
Galiano Gold
IHG69.140.56
+0.82%
InterContinental Hotels Group Plc
HSCS1.02N/A
N/A
Heart Test Laboratories
SEAT7.79-0.05
-0.64%
Vivid Seats
FCPT26.36-0.30
-1.13%
Four Corners Property Trust

AEMD and

Correlation & Price change

A.I.dvisor tells us that AEMD and APDN have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AEMD and APDN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AEMD
1D Price
Change %
AEMD100%
-3.15%
APDN - AEMD
29%
Poorly correlated
-6.83%
AXNX - AEMD
27%
Poorly correlated
+1.49%
NVRO - AEMD
26%
Poorly correlated
+2.08%
ISRG - AEMD
26%
Poorly correlated
+1.17%
INMD - AEMD
25%
Poorly correlated
+0.06%
More

STE and

Correlation & Price change

A.I.dvisor indicates that over the last year, STE has been loosely correlated with GMED. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if STE jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STE
1D Price
Change %
STE100%
-0.84%
GMED - STE
60%
Loosely correlated
-0.32%
SYK - STE
59%
Loosely correlated
-0.45%
BDX - STE
55%
Loosely correlated
-0.72%
COO - STE
55%
Loosely correlated
-0.28%
MDT - STE
55%
Loosely correlated
+0.26%
More